Andrew Parratt is a senior pharma/biotech executive with more than 25 years of Commercial, Strategy and Operations experience. He is currently the Vice President of Commercial Planning and Operations for Karuna Therapeutics. Andrew has built his career turning great science into commercial success, orchestrating cross-functional collaborations to identify synergies and enable organizations to scale and commercialize. He develops long-term roadmaps and corporate strategies that define how individual functions are interdependent in their efforts to move promising compounds from Phase I to maturity. Andrew holds a Postgraduate Diploma in Marketing from the Chartered Institute of Marketing in London. He earned a First Class Honors Bachelor of Science in Chemistry for Europe (French) from the University of Surrey, UK / Ecole de Chimie, France.
Krista supports biopharma and biotech companies in their new product planning, launch strategy & planning, and commercialization readiness. She leads Trinity’s launch excellence group, supporting the development and management of dozens of launches annually. Krista partners with companies focused on their 1stcommercial launch to their 50th, bringing deep expertise in rare diseases. Clients leverage Krista’s experience and insights in navigating early-mid clinical stage product development opportunities and the commercial needs required to recognize their full potential, specializing in cross-functional activities that warrant communication & alignment. Krista joined Trinity in 2006 and co-leads the SF office. Krista studied psychology and pre-med while obtaining her B.A. from Dartmouth College. She enjoys spending time outside with her family in Idaho.
With emerging biotech needing help with a little bit of everything, these preferred partnerships can deliver a type of one-stop shopping leveraging an agency’s best practices, current trends, and data.